» Articles » PMID: 9070968

Comparison of Resting Beta-methyl-iodophenyl Pentadecanoic Acid (BMIPP) and Thallium-201 Tomography Using Quantitative Polar Maps in Patients with Unstable Angina

Overview
Journal Jpn Circ J
Date 1997 Feb 1
PMID 9070968
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We compared resting beta-methyl-iodophenyl pentadecanoic acid (BMIPP) tomography with resting thallium-201 tomography in 28 patients with unstable angina. Tracer distribution was displayed on a polar map and compared with a normal standard deviation map obtained from a group of 12 normal subjects. The extent scores and severity scores obtained by BMIPP were significantly greater than those obtained by thallium-201. Confirmation by coronary angiography revealed the sensitivity of the methods in identifying patients to be 89% for BMIPP and 54% for thallium-201. There were significant differences between BMIPP and thallium-201 in the sensitivities of detecting postischemic jeopardized myocardium in the area supplied by the right coronary artery (RCA; 53% vs 18%, p < 0.05), left circumflex artery (LCX; 78% vs 39%, p < 0.025) and all 3 vessels combined (71% vs 35%, p < 0.001) but no significant differences in specificity (RCA: 82% vs 64%; LCX: 70% vs 90%; and total 3 vessels combined: 75% vs 79%). In conclusion, resting BMIPP tomography is more sensitive than resting thallium-201 tomography in detecting postischemic myocardial damage in patients with unstable angina.

Citing Articles

Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations.

Yoshinaga K, Naya M, Shiga T, Suzuki E, Tamaki N Eur J Nucl Med Mol Imaging. 2013; 41(2):384-93.

PMID: 24218099 DOI: 10.1007/s00259-013-2615-4.


Novel iodinated tracers, MIBG and BMIPP, for nuclear cardiology.

Tamaki N, Yoshinaga K J Nucl Cardiol. 2010; 18(1):135-43.

PMID: 21082300 PMC: 3032201. DOI: 10.1007/s12350-010-9305-4.


Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease.

Nishimura M, Ono T J Nucl Cardiol. 2008; 15(6):830-7.

PMID: 18984459 DOI: 10.1007/BF03007365.


The Japanese experience with metabolic imaging in the clinical setting.

Tamaki N, Morita K, Kawai Y J Nucl Cardiol. 2007; 14(3 Suppl):S145-52.

PMID: 17556183 DOI: 10.1016/j.nuclcard.2007.02.012.


Metabolic imaging using SPECT.

Taki J, Matsunari I Eur J Nucl Med Mol Imaging. 2007; 34 Suppl 1:S34-48.

PMID: 17479263 DOI: 10.1007/s00259-007-0439-9.